Global Pharmaceutical Contract Manufacturing Market 2024-2028
상품코드:1559403
리서치사:TechNavio
발행일:2024년 08월
페이지 정보:영문 164 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
의약품 수탁제조 시장은 2023-2028년간 648억 달러 확대되고, 예측 기간 동안 8.1%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 이 보고서는 의약품 수탁제조 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 특허 만료, 제네릭 의약품에 대한 수요 증가, 핵심 역량에 대한 집중 요구 증가, 강력한 연구 자금 등이 시장을 주도하고 있습니다.
시장 범위
기준년도
2024년
종료년도
2028년
예측 기간
2024-2028년
성장 모멘텀
가속
2024년 전년 대비
7.35%
CAGR
8.1%
증분 금액
648억 달러
이 보고서는 향후 수년간 의약품 수탁제조 시장의 성장을 가속하는 주요 요인 중 하나로 미국 FDA 승인 제조 시설 증가를 꼽았습니다. 또한, 생물학적 치료제에 대한 수요 증가와 빅데이터의 출현은 시장의 큰 수요로 이어질 것입니다.
The pharmaceutical contract manufacturing market is forecasted to grow by USD 64.8 bn during 2023-2028, accelerating at a CAGR of 8.1% during the forecast period. The report on the pharmaceutical contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by patent expiry and increasing demand for generic drugs, growing need to focus on core competencies, and strong research funding.
Market Scope
Base Year
2024
End Year
2028
Series Year
2024-2028
Growth Momentum
Accelerate
YOY 2024
7.35%
CAGR
8.1%
Incremental Value
$64.8 bn
Technavio's pharmaceutical contract manufacturing market is segmented as below:
By End-user
Big pharmaceutical companies
Small and medium-sized pharmaceutical companies
Generic pharmaceutical companies
By Service
API/bulk drug manufacturing
Final dosage form
Secondary packaging
By Geographical Landscape
North America
Asia
Europe
Rest of World (ROW)
This study identifies the increasing number of US fda-approved manufacturing facilities as one of the prime reasons driving the pharmaceutical contract manufacturing market growth during the next few years. Also, rising demand for biological therapies and advent of big data will lead to sizable demand in the market.
The report on the pharmaceutical contract manufacturing market covers the following areas:
Pharmaceutical contract manufacturing market industry analysis
The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical contract manufacturing market vendors that include AbbVie Inc., Almac Group Ltd., Baxter International Inc., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Charles River Laboratories International Inc., Cmic Holdings Co. Ltd, Dalton Pharma Services, DR Reddys Laboratories Ltd., Grifols SA, Laboratory Corp. of America Holdings, Lonza Group Ltd., Lupin Ltd., Novotech Health Holdings, OPTIMAPHARM d.o.o., Parexel International Corp., PCI Pharma Services, Recipharm AB, Syneos Health Inc., and Thermo Fisher Scientific Inc.. Also, the pharmaceutical contract manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Service
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Pharmaceutical Contract Manufacturing Market 2018 - 2022
Historic Market Size - Data Table on Global Pharmaceutical Contract Manufacturing Market 2018 - 2022 ($ billion)
